المؤلفون: Flaadt T; Department of Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany., Ladenstein RL; St Anna Children's Hospital and Children's Cancer Research Institute, Department of Studies and Statistics for Integrated Research and Projects, Medical University of Vienna, Vienna, Austria.; Department of Pediatrics, Medical University of Vienna, Vienna, Austria., Ebinger M; Department of Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany., Lode HN; Department of Pediatric Hematology and Oncology, University Medicine Greifswald, Greifswald, Germany., Arnardóttir HB; Department for Studies and Statistics and Integrated Research, Children's Cancer Research Institute, Vienna, Austria., Poetschger U; Department for Studies and Statistics and Integrated Research, Children's Cancer Research Institute, Vienna, Austria., Schwinger W; Division of Pediatric Hematology-Oncology, Department of Pediatrics and Adolescent Medicine, Medical University Graz, Graz, Austria., Meisel R; Division of Pediatric Stem Cell Therapy, Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich Heine University, Duesseldorf, Germany., Schuster FR; Division of Pediatric Stem Cell Therapy, Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich Heine University, Duesseldorf, Germany., Döring M; Department of Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany., Ambros PF; CCRI, Children's Cancer Research Institute, Vienna, Department of Tumor Biology and Department of Pediatrics, Medical University of Vienna, Vienna, Austria., Queudeville M; Department of Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany., Fuchs J; Department of Pediatric Surgery and Pediatric Urology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany., Warmann SW; Department of Pediatric Surgery and Pediatric Urology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany., Schäfer J; Department for Diagnostic and Interventional Radiology, University Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany., Seitz C; Department of Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany.; Cluster of Excellence iFIT (Exc 2180) 'Image-guided and Functionally Instructed Tumor Therapies,' University of Tuebingen, Germany., Schlegel P; Children's Medical Research Institute, The Cancer Centre for Children, The Children's Hospital Westmead, University of Sydney, Sydney, Australia., Brecht IB; Department of Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany., Holzer U; Department of Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany., Feuchtinger T; Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Dr von Hauner Children's Hospital, University Hospital, Ludwig Maximilians University Munich, Munich, Germany., Simon T; Department of Pediatric Oncology and Hematology, University Hospital, University of Cologne, Cologne, Germany., Schulte JH; Department of Pediatric Oncology/Hematology, Charité-Universitaetsmedizin Berlin, Berlin, Germany., Eggert A; Department of Pediatric Oncology/Hematology, Charité-Universitaetsmedizin Berlin, Berlin, Germany., Teltschik HM; Department of Hematology and Oncology, Children's Hospital Stuttgart-Olgahospital, Stuttgart, Germany., Illhardt T; Department of Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany., Handgretinger R; Department of Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany., Lang P; Department of Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany.; Cluster of Excellence iFIT (Exc 2180) 'Image-guided and Functionally Instructed Tumor Therapies,' University of Tuebingen, Germany.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Jun 10; Vol. 41 (17), pp. 3135-3148. Date of Electronic Publication: 2023 Feb 28.

نوع المنشور: Clinical Trial, Phase II; Clinical Trial, Phase I; Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Neuroblastoma*/drug therapy , Hematopoietic Stem Cell Transplantation*/adverse effects , Hematopoietic Stem Cell Transplantation*/methods , Graft vs Host Disease*/etiology, Humans ; Infant ; Child, Preschool ; Child ; Adolescent ; Young Adult ; Adult ; Interleukin-2/therapeutic use ; Neoplasm Recurrence, Local/therapy ; Neoplasm Recurrence, Local/etiology

المؤلفون: Knörr F; Pediatric Hematology and Oncology, University Medical Center Hospital Hamburg-Eppendorf, Hamburg, Germany; Mildred Scheel Cancer Career Center HaTriCS4, University Medical Center Hamburg-Eppendorf, Hamburg. f.knoerr@uke.de., Schellekens KPJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Erasmus Medical Center, Sophia Children's Hospital, Rotterdam., Schoot RA; Princess Máxima Center for Pediatric Oncology, Utrecht., Landman-Parker J; Pediatric Hematology, Immunology, Oncology, Sorbonne université, Hôpital Armand Trousseau, APHP, Paris., Teltschik HM; Pediatrics 5 (Oncology, Hematology, and Immunology), Olgahospital, Stuttgart., Förster J; Pediatric Hematology and Oncology, University Medical Center Hospital Hamburg-Eppendorf, Hamburg., Riquelme A; Pediatric Hematology and Oncology, University Medical Center Hospital Hamburg-Eppendorf, Hamburg., Huitema ADR; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Dept. Pharmacy and Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Dept. Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht., Van Eijkelenburg NKA; Princess Máxima Center for Pediatric Oncology, Utrecht., Beishuizen A; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Erasmus Medical Center, Sophia Children's Hospital, Rotterdam., Zwaan CM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Erasmus Medical Center, Sophia Children's Hospital, Rotterdam., Woessmann W; Pediatric Hematology and Oncology, University Medical Center Hospital Hamburg-Eppendorf, Hamburg., Van der Lugt J; Princess Máxima Center for Pediatric Oncology, Utrecht.

المصدر: Haematologica [Haematologica] 2023 May 01; Vol. 108 (5), pp. 1442-1446. Date of Electronic Publication: 2023 May 01.

نوع المنشور: Letter; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

مواضيع طبية MeSH: Vinblastine* , Lymphoma, Large-Cell, Anaplastic*/pathology, Child ; Humans ; Crizotinib ; Receptor Protein-Tyrosine Kinases ; Anaplastic Lymphoma Kinase

المؤلفون: Eichholz T; University Children's Hospital, Eberhard Karls University, Tuebingen, Germany., Döring M; University Children's Hospital, Eberhard Karls University, Tuebingen, Germany., Giardino S; Hematopoietic Stem Cell Transplantation Unit, Department of Hematology and Oncology, IRCCS Istituto Giannina Gaslini, Genoa, Italy., Gruhn B; Department of Pediatrics, Jena University Hospital, Jena, Germany., Seitz C; University Children's Hospital, Eberhard Karls University, Tuebingen, Germany., Flaadt T; University Children's Hospital, Eberhard Karls University, Tuebingen, Germany., Schwinger W; Department of Pediatrics and Adolescent Medicine, Medical University of Graz, Graz, Austria., Ebinger M; University Children's Hospital, Eberhard Karls University, Tuebingen, Germany., Holzer U; University Children's Hospital, Eberhard Karls University, Tuebingen, Germany., Mezger M; University Children's Hospital, Eberhard Karls University, Tuebingen, Germany., Teltschik HM; Klinikum der Landeshauptstadt Stuttgart gKAöR, Olgahospital, Stuttgart Cancer Center, Zentrum für Kinder-, Jugend- und Frauenmedizin, Pädiatrie 5 (Pädiatrische Onkologie, Hämatologie, Immunologie), Stuttgart, Germany., Sparber-Sauer M; Klinikum der Landeshauptstadt Stuttgart gKAöR, Olgahospital, Stuttgart Cancer Center, Zentrum für Kinder-, Jugend- und Frauenmedizin, Pädiatrie 5 (Pädiatrische Onkologie, Hämatologie, Immunologie), Stuttgart, Germany.; University Tübingen, Medical Faculty, Tübingen, Germany., Koscielniak E; Klinikum der Landeshauptstadt Stuttgart gKAöR, Olgahospital, Stuttgart Cancer Center, Zentrum für Kinder-, Jugend- und Frauenmedizin, Pädiatrie 5 (Pädiatrische Onkologie, Hämatologie, Immunologie), Stuttgart, Germany.; University Tübingen, Medical Faculty, Tübingen, Germany., Abele M; University Children's Hospital, Eberhard Karls University, Tuebingen, Germany., Handgretinger R; University Children's Hospital, Eberhard Karls University, Tuebingen, Germany., Lang P; University Children's Hospital, Eberhard Karls University, Tuebingen, Germany.

المصدر: Frontiers in oncology [Front Oncol] 2023 Feb 21; Vol. 13, pp. 1064190. Date of Electronic Publication: 2023 Feb 21 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

المؤلفون: Wegener D; Department of Radiation Oncology, University of Tuebingen, Tuebingen, Germany., Lang P; Department of Paediatrics I, Hematology and Oncology, Tuebingen, Germany., Paulsen F; Department of Radiation Oncology, University of Tuebingen, Tuebingen, Germany., Weidner N; Department of Radiation Oncology, University of Tuebingen, Tuebingen, Germany., Zips D; Department of Radiation Oncology, University of Tuebingen, Tuebingen, Germany., Ebinger M; Department of Paediatrics I, Hematology and Oncology, Tuebingen, Germany., Holzer U; Department of Paediatrics I, Hematology and Oncology, Tuebingen, Germany., Döring M; Department of Paediatrics I, Hematology and Oncology, Tuebingen, Germany., Basu O; Centre for Children`s Medicine, University Clinic of Essen, Essen, Germany., Gruhn B; Department of Pediatrics, Jena University Hospital, Jena, Germany., Wittig A; Department of Radiation Oncology, Jena University Hospital, Jena, Germany., Teltschik HM; Department of Pediatric Oncology, Hematology and Immunology, Olgahospital, Stuttgart, Germany., Handgretinger R; Department of Paediatrics I, Hematology and Oncology, Tuebingen, Germany., Heinzelmann F; Department of Radiation Oncology, University of Tuebingen, Tuebingen, Germany. Electronic address: frank.heinzelmann@med.uni-tuebingen.de.

المصدر: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2019 May 01; Vol. 104 (1), pp. 137-143. Date of Electronic Publication: 2018 Dec 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-355X (Electronic) Linking ISSN: 03603016 NLM ISO Abbreviation: Int J Radiat Oncol Biol Phys Subsets: MEDLINE

مواضيع طبية MeSH: Graft Rejection* , Hematopoietic Stem Cell Transplantation*, Immunosuppression Therapy/*methods , Lymphatic Irradiation/*methods , Transplantation Conditioning/*methods, Adolescent ; Allografts ; Antilymphocyte Serum/therapeutic use ; Bone Marrow Transplantation ; Child ; Child, Preschool ; Follow-Up Studies ; Humans ; Immunologic Factors/therapeutic use ; Immunosuppression Therapy/adverse effects ; Kaplan-Meier Estimate ; Lymphatic Irradiation/adverse effects ; Muromonab-CD3/therapeutic use ; Myeloablative Agonists/therapeutic use ; Radiotherapy Dosage ; Retreatment/adverse effects ; Retreatment/methods ; Retrospective Studies ; Thiotepa/therapeutic use ; Transplantation Conditioning/adverse effects ; Vidarabine/analogs & derivatives ; Vidarabine/therapeutic use ; Young Adult

المؤلفون: Illhardt T; Department of Pediatrics, Children's University Hospital, University of Tübingen, Tübingen, Germany., Toporski J; Department of Pediatrics, Skåne University Hospital, Lund, Sweden., Feuchtinger T; Department of Pediatrics, Children's University Hospital, University of Tübingen, Tübingen, Germany; Department of Pediatrics, Dr. von Hauner Children's Hospital, University Children's Hospital, Munich, Germany., Turkiewicz D; Department of Pediatrics, Skåne University Hospital, Lund, Sweden., Teltschik HM; Department of Pediatrics, Children's University Hospital, University of Tübingen, Tübingen, Germany., Ebinger M; Department of Pediatrics, Children's University Hospital, University of Tübingen, Tübingen, Germany., Schwarze CP; Department of Pediatrics, Children's University Hospital, University of Tübingen, Tübingen, Germany., Holzer U; Department of Pediatrics, Children's University Hospital, University of Tübingen, Tübingen, Germany., Lode HN; Department of Pediatrics, Children's University Hospital, University of Greifswald, Greifswald, Germany., Albert MH; Department of Pediatrics, Dr. von Hauner Children's Hospital, University Children's Hospital, Munich, Germany., Gruhn B; Department of Pediatrics, Jena University Hospital, Jena, Germany., Urban C; Department of Pediatrics, Children's University Hospital, Medical University of Graz, Graz, Austria., Dykes JH; Department of Clinical Immunology and Transfusion Medicine, Office for Medical Services, Region Skåne, Lund, Sweden; Department of Laboratory Medicine, Lund University, Lund, Sweden., Teuffel O; Department of Pediatrics, Children's University Hospital, University of Tübingen, Tübingen, Germany; Medical Service of the Statutory Health Fund, Baden-Wuerttemberg, Germany., Schumm M; Department of Pediatrics, Children's University Hospital, University of Tübingen, Tübingen, Germany., Handgretinger R; Department of Pediatrics, Children's University Hospital, University of Tübingen, Tübingen, Germany., Lang P; Department of Pediatrics, Children's University Hospital, University of Tübingen, Tübingen, Germany. Electronic address: peter.lang@med.uni-tuebingen.de.

المصدر: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2018 May; Vol. 24 (5), pp. 1005-1012. Date of Electronic Publication: 2018 Jan 04.

نوع المنشور: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Carden Jennings Publishing Country of Publication: United States NLM ID: 9600628 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-6536 (Electronic) Linking ISSN: 10838791 NLM ISO Abbreviation: Biol Blood Marrow Transplant Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation/*methods , Neuroblastoma/*therapy , Salvage Therapy/*methods , Transplantation, Haploidentical/*methods, Adolescent ; Antigens, CD34/blood ; Antineoplastic Combined Chemotherapy Protocols ; Child ; Child, Preschool ; Graft vs Host Disease ; Hematopoietic Stem Cell Transplantation/mortality ; Humans ; Lymphocyte Depletion ; Neuroblastoma/mortality ; Prognosis ; Salvage Therapy/mortality ; Survival Analysis ; Transplantation Conditioning ; Transplantation, Haploidentical/mortality ; Treatment Outcome

المؤلفون: Mainardi C; Department of Paediatric Oncology, Children's University Hospital, University of Padova, Padova, Italy.; Department of Paediatric Haematology/Oncology, Children's University Hospital, Tübingen, Germany., Ebinger M; Department of Paediatric Haematology/Oncology, Children's University Hospital, Tübingen, Germany., Enkel S; Transfusion Medicine Department, Tübingen University Hospital, University of Tübingen, Tübingen, Germany., Feuchtinger T; Dr. von Hauner Children's Hospital, Ludwig Maximilians University, Munich, Germany., Teltschik HM; Department of Paediatric Haematology/Oncology, Children's University Hospital, Tübingen, Germany., Eyrich M; Department of Paediatric Oncology, University Children's Hospital, University of Würzburg, Würzburg, Germany., Schumm M; Department of Paediatric Haematology/Oncology, Children's University Hospital, Tübingen, Germany., Rabsteyn A; Department of Paediatric Haematology/Oncology, Children's University Hospital, Tübingen, Germany., Schlegel P; Department of Paediatric Haematology/Oncology, Children's University Hospital, Tübingen, Germany., Seitz C; Department of Paediatric Haematology/Oncology, Children's University Hospital, Tübingen, Germany., Schwarze CP; Department of Paediatric Haematology/Oncology, Children's University Hospital, Tübingen, Germany., Müller I; Department of Paediatric Haematology and Oncology, University Hospital Eppendorf, Hamburg, Germany., Greil J; Department of Paediatric Oncology, Haematology and Immunology, University of Heidelberg, Heidelberg, Germany., Bader P; Clinic for Paediatric and Adolescent Medicine, University Hospital Frankfurt, Frankfurt/Main, Germany., Schlegel PG; Department of Paediatric Oncology, University Children's Hospital, University of Würzburg, Würzburg, Germany., Martin D; Department of Paediatric Haematology/Oncology, Children's University Hospital, Tübingen, Germany.; Filderklinik, Filderstadt-Bonlanden, Germany., Holzer U; Department of Paediatric Haematology/Oncology, Children's University Hospital, Tübingen, Germany., Döring M; Department of Paediatric Haematology/Oncology, Children's University Hospital, Tübingen, Germany., Handgretinger R; Department of Paediatric Haematology/Oncology, Children's University Hospital, Tübingen, Germany., Lang P; Department of Paediatric Haematology/Oncology, Children's University Hospital, Tübingen, Germany.

المصدر: British journal of haematology [Br J Haematol] 2018 Jan; Vol. 180 (1), pp. 90-99. Date of Electronic Publication: 2017 Dec 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Graft Survival* , Hematopoietic Stem Cell Transplantation*/adverse effects , Hematopoietic Stem Cell Transplantation*/methods , Hematopoietic Stem Cells*/metabolism, Adolescent ; Adult ; Antigens, CD34/metabolism ; Cell Lineage ; Child ; Child, Preschool ; Cohort Studies ; Female ; Graft vs Host Disease/etiology ; Hematopoiesis ; Humans ; Infant ; Male ; Prognosis ; Retreatment ; Retrospective Studies ; Transplantation Chimera ; Transplantation Conditioning ; Transplantation, Homologous ; Treatment Outcome ; Young Adult

المؤلفون: Teltschik HM; Children's University Hospital, University Hospital (UH) of Tuebingen, Tuebingen, Germany., Heinzelmann F; Department of Radiation Oncology, UH of Tuebingen, Tuebingen, Germany., Gruhn B; Children's University Hospital, UH of Jena, Jena, Germany., Feuchtinger T; Dr. von Hauner'sches Kinderspital, Ludwig-Maximilians-Universität Munich, Munich, Germany., Schlegel P; Children's University Hospital, University Hospital (UH) of Tuebingen, Tuebingen, Germany., Schumm M; Children's University Hospital, University Hospital (UH) of Tuebingen, Tuebingen, Germany., Kremens B; Children's University Hospital, UH of Essen, Essen, Germany., Müller I; Clinic for Paediatric Haematology and Oncology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany., Ebinger M; Children's University Hospital, University Hospital (UH) of Tuebingen, Tuebingen, Germany., Schwarze CP; Children's University Hospital, University Hospital (UH) of Tuebingen, Tuebingen, Germany., Ottinger H; Department of Bone Marrow Transplantation, UH of Essen, Essen, Germany., Zips D; Department of Radiation Oncology, UH of Tuebingen, Tuebingen, Germany., Handgretinger R; Children's University Hospital, University Hospital (UH) of Tuebingen, Tuebingen, Germany., Lang P; Children's University Hospital, University Hospital (UH) of Tuebingen, Tuebingen, Germany. peter.lang@med.uni-tuebingen.de.

المصدر: British journal of haematology [Br J Haematol] 2016 Oct; Vol. 175 (1), pp. 115-22. Date of Electronic Publication: 2016 Jun 24.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Haplotypes* , Hematopoietic Stem Cell Transplantation*/adverse effects , Hematopoietic Stem Cell Transplantation*/methods , Transplantation Conditioning*/methods, Graft Rejection/*therapy , HLA Antigens/*genetics, Adolescent ; Adult ; Child ; Child, Preschool ; Female ; Graft Rejection/mortality ; Graft Survival ; Graft vs Host Disease/etiology ; Hematologic Diseases/diagnosis ; Hematologic Diseases/mortality ; Hematologic Diseases/therapy ; Hematopoietic Stem Cell Mobilization/methods ; Humans ; Infant ; Lymphocyte Depletion ; Male ; Retreatment ; Transplantation Chimera ; Transplantation, Homologous ; Treatment Outcome ; Young Adult

المؤلفون: Seidel UJ; Department of General Pediatrics, Hematology/Oncology, University Children's Hospital Tübingen, Tübingen, Germany., Schlegel P; Department of General Pediatrics, Hematology/Oncology, University Children's Hospital Tübingen, Tübingen, Germany., Grosse-Hovest L; SYNIMMUNE GmbH, Tübingen, Germany.; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany., Hofmann M; SYNIMMUNE GmbH, Tübingen, Germany.; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany., Aulwurm S; SYNIMMUNE GmbH, Tübingen, Germany.; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany., Pyz E; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany., Schuster FR; Department of Pediatric Oncology, Hematology and Immunology, Heinrich Heine University, Düsseldorf, Germany., Meisel R; Department of Pediatric Oncology, Hematology and Immunology, Heinrich Heine University, Düsseldorf, Germany., Ebinger M; Department of General Pediatrics, Hematology/Oncology, University Children's Hospital Tübingen, Tübingen, Germany., Feuchtinger T; Department of Pediatric Oncology/Hematology, Ludwig Maximilians University Munich, München, Germany., Teltschik HM; Department of General Pediatrics, Hematology/Oncology, University Children's Hospital Tübingen, Tübingen, Germany., Witte KE; Department of General Pediatrics, Hematology/Oncology, University Children's Hospital Tübingen, Tübingen, Germany., Schwarze CP; Department of General Pediatrics, Hematology/Oncology, University Children's Hospital Tübingen, Tübingen, Germany., Rammensee HG; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tübingen, Tübingen, Germany., Handgretinger R; Department of General Pediatrics, Hematology/Oncology, University Children's Hospital Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tübingen, Tübingen, Germany., Jung G; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tübingen, Tübingen, Germany., Lang P; Department of General Pediatrics, Hematology/Oncology, University Children's Hospital Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tübingen, Tübingen, Germany.

المصدر: Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2016 Sep; Vol. 24 (9), pp. 1634-43. Date of Electronic Publication: 2016 Jul 06.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 100890581 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-0024 (Electronic) Linking ISSN: 15250016 NLM ISO Abbreviation: Mol Ther Subsets: MEDLINE

مواضيع طبية MeSH: Antigens, CD19*/immunology , Antigens, CD19*/metabolism , Immunoglobulin Fc Fragments*/immunology, Antibodies, Monoclonal/*therapeutic use , Neoplasm, Residual/*drug therapy , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/*diagnosis , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/*drug therapy, Adolescent ; Antibodies, Monoclonal/pharmacology ; Antibody-Dependent Cell Cytotoxicity ; Cell Line, Tumor ; Child ; Child, Preschool ; Combined Modality Therapy ; Drug Monitoring ; Drug Resistance, Neoplasm ; Female ; Gene Expression ; Humans ; Kaplan-Meier Estimate ; Male ; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/genetics ; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/metabolism ; Retreatment ; Treatment Outcome ; Young Adult

المؤلفون: Döring M; Department I - General Paediatrics, Hematology/Oncology, Children's Hospital, University Hospital Tuebingen, Hoppe-Seyler-Str. 1, 72076, Tuebingen, Germany. michaela.doering@med.uni-tuebingen.de.; Dr. von Hauner'sches Kinderspital, Pediatric Hematology, Oncology and Stem Cell Transplantation, Ludwig-Maximilians-University München, Lindwurmstrasse 4, 80337, Munich, Germany. michaela.doering@med.uni-tuebingen.de., Cabanillas Stanchi KM; Department I - General Paediatrics, Hematology/Oncology, Children's Hospital, University Hospital Tuebingen, Hoppe-Seyler-Str. 1, 72076, Tuebingen, Germany. karin.cabanillas@med.uni-tuebingen.de., Feucht J; Department I - General Paediatrics, Hematology/Oncology, Children's Hospital, University Hospital Tuebingen, Hoppe-Seyler-Str. 1, 72076, Tuebingen, Germany. judith.feucht@med.uni-tuebingen.de., Queudeville M; Department I - General Paediatrics, Hematology/Oncology, Children's Hospital, University Hospital Tuebingen, Hoppe-Seyler-Str. 1, 72076, Tuebingen, Germany. manon.queudeville@med.uni-tuebingen.de., Teltschik HM; Department I - General Paediatrics, Hematology/Oncology, Children's Hospital, University Hospital Tuebingen, Hoppe-Seyler-Str. 1, 72076, Tuebingen, Germany. heiko-manuel.teltschik@med.uni-tuebingen.de., Lang P; Department I - General Paediatrics, Hematology/Oncology, Children's Hospital, University Hospital Tuebingen, Hoppe-Seyler-Str. 1, 72076, Tuebingen, Germany. peter.lang@med.uni-tuebingen.de., Feuchtinger T; Department I - General Paediatrics, Hematology/Oncology, Children's Hospital, University Hospital Tuebingen, Hoppe-Seyler-Str. 1, 72076, Tuebingen, Germany. tobias.feuchtinger@med.uni-muenchen.de.; Dr. von Hauner'sches Kinderspital, Pediatric Hematology, Oncology and Stem Cell Transplantation, Ludwig-Maximilians-University München, Lindwurmstrasse 4, 80337, Munich, Germany. tobias.feuchtinger@med.uni-muenchen.de., Handgretinger R; Department I - General Paediatrics, Hematology/Oncology, Children's Hospital, University Hospital Tuebingen, Hoppe-Seyler-Str. 1, 72076, Tuebingen, Germany. rupert.handgretinger@med.uni-tuebingen.de., Müller I; Department of Paediatric Hematology and Oncology, University Hospital Hamburg-Eppendorf, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany. i.mueller@uke.de.

المصدر: Annals of hematology [Ann Hematol] 2016 Jan; Vol. 95 (2), pp. 311-23. Date of Electronic Publication: 2015 Nov 27.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Ferritins/*blood , Graft Rejection/*blood , Graft Rejection/*diagnosis , Hematologic Neoplasms/*blood , Hematologic Neoplasms/*therapy , Hematopoietic Stem Cell Transplantation/*trends, Adolescent ; Biomarkers/blood ; Child ; Child, Preschool ; Female ; Graft Rejection/etiology ; Hematologic Neoplasms/diagnosis ; Hematopoietic Stem Cell Transplantation/adverse effects ; Humans ; Infant ; Male ; Retrospective Studies ; Transplantation Conditioning/adverse effects ; Transplantation Conditioning/trends ; Transplantation, Homologous/adverse effects ; Transplantation, Homologous/trends

المؤلفون: Lang P; Children's University Hospital, University of Tuebingen, Tuebingen, Germany., Feuchtinger T; Children's University Hospital, University of Tuebingen, Tuebingen, Germany., Teltschik HM; Children's University Hospital, University of Tuebingen, Tuebingen, Germany., Schwinger W; Children's University Hospital, Medical University of Graz, Graz, Austria., Schlegel P; Children's University Hospital, University of Tuebingen, Tuebingen, Germany., Pfeiffer M; Children's University Hospital, University of Tuebingen, Tuebingen, Germany., Schumm M; Children's University Hospital, University of Tuebingen, Tuebingen, Germany., Lang AM; Children's University Hospital, University of Tuebingen, Tuebingen, Germany., Lang B; Children's University Hospital, University of Tuebingen, Tuebingen, Germany., Schwarze CP; Children's University Hospital, University of Tuebingen, Tuebingen, Germany., Ebinger M; Children's University Hospital, University of Tuebingen, Tuebingen, Germany., Urban C; Children's University Hospital, Medical University of Graz, Graz, Austria., Handgretinger R; Children's University Hospital, University of Tuebingen, Tuebingen, Germany.

المصدر: Bone marrow transplantation [Bone Marrow Transplant] 2015 Jun; Vol. 50 Suppl 2, pp. S6-10.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE

مواضيع طبية MeSH: Antigens, CD19* , Hematopoietic Stem Cell Transplantation* , Leukemia, Myeloid, Acute*/immunology , Leukemia, Myeloid, Acute*/therapy , Myelodysplastic Syndromes*/immunology , Myelodysplastic Syndromes*/therapy , Precursor Cell Lymphoblastic Leukemia-Lymphoma* , Receptors, Antigen, T-Cell, alpha-beta*, Lymphocyte Depletion/*instrumentation , Recovery of Function/*immunology , Transplantation Conditioning/*methods, Adolescent ; Allografts ; B-Lymphocytes/immunology ; Child ; Child, Preschool ; Female ; Humans ; Male ; Retrospective Studies ; T-Lymphocytes/immunology ; Tissue Donors